# US 2023/0147612 A1 · Nutritional health supplements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0147612 A1
- Document ID: US20230147612A1
- Status: Published application
- Kind: A1
- Application number: 17/912,570
- Filed: 2020-11-23
- Published: 2023-05-11
- Earliest claimed: 2020-03-19
- Assignees: Mayo Foundation for Medical Education and Research
- Applicants: Mayo Foundation for Medical Education and Research
- Inventors: DAVID W DODICK
- Web page: https://patentgrep.com/patent/US20230147612A1

## CPC

- A61K 31/202: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
- A23L 2/39: Dry compositions
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/15: Vitamins
- A23L 33/16: Inorganic salts, minerals or trace elements
- A23L 33/175: Amino acids
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/12: Ketones
- A61K 31/121: acyclic
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/525: Isoalloxazines, e.g. riboflavins, vitamin B2
- A61K 31/706: containing six-membered rings with nitrogen as a ring hetero atom
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 38/063: {Glutathione}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

A nutritional health supplement is provided for the brain. In one exemplary embodiment, a nutritional health supplement comprises a first neuroprotective agent having antioxidant, anti-inflammatory, anti-apoptic, anti-autophagic, and anti-cerebral edema properties, and having calcium-induced apoptotic signaling-inhibiting properties; a second neuroprotective agent having glutamate-mediated excitotoxicity-mitigating and calcium influx-mitigating properties and having antioxidant and blood-brain barrier protecting properties; a third neuroprotective agent that is a precursor for glutathione synthesis and has calcium influx-mitigating and anti-oxidative stress mediating properties and that augments the first neuroprotective agent's calcium-induced apoptotic signaling-inhibiting properties and anti-cerebral edema properties and the second neuroprotective agent's antioxidant properties; a NAD+ precursor that augments the first neuroprotective agent's anti-apoptotic properties, the second neuroprotective agent's glutamate-mediated excitotoxicity-mitigating and blood-brain barrier protecting properties, and the third neuroprotective agent's calcium influx-mitigating and anti-oxidative stress mediating properties. The second neuroprotective agent augments the third neuroprotective agent's calcium influx-reducing property.

## Claims

### Claim 1

A nutritional health supplement, comprising:
a first neuroprotective agent, the first neuroprotective agent having antioxidant, anti-inflammatory, anti-apoptic, anti-autophagic, and anti-cerebral edema properties, and having calcium-induced apoptotic signaling-inhibiting properties;
a second neuroprotective agent, the second neuroprotective agent having glutamate-mediated excitotoxicity-mitigating and calcium influx-mitigating properties and having antioxidant and blood-brain barrier protecting properties;
a third neuroprotective agent that is a precursor for glutathione synthesis and has calcium influx-mitigating and anti-oxidative stress mediating properties, wherein the third neuroprotective agent augments the first neuroprotective agent's calcium-induced apoptotic signaling-inhibiting properties and anti-cerebral edema properties and the second neuroprotective agent's antioxidant properties; and
a NAD+ precursor, wherein the NAD+ precursor augments the first neuroprotective agent's anti-apoptotic properties, the second neuroprotective agent's glutamate-mediated excitotoxicity-mitigating and blood-brain barrier protecting properties, and the third neuroprotective agent's calcium influx-mitigating and anti-oxidative stress mediating properties,
wherein the second neuroprotective agent augments the third neuroprotective agent's calcium influx-reducing property.

### Claim 2 (depends on 1)

The nutritional health supplement of claim 1, wherein the first neuroprotective agent comprises resveratrol.

### Claim 3 (depends on 1)

The nutritional health supplement of claim 1, wherein the second neuroprotective agent comprises docosahexaenoic acid.

### Claim 4 (depends on 1)

The nutritional health supplement of claim 1, wherein the third neuroprotective agent comprises n-acetyl cysteine.

### Claim 5 (depends on 1)

The nutritional health supplement of claim 1, wherein the NAD+ precursor comprises nicotinamide riboside.

### Claim 6 (depends on 1)

The nutritional health supplement of claim 1, further comprising a ketone body, a ketone precursor, or a combination thereof.

### Claim 7 (depends on 6)

The nutritional health supplement of claim 6, wherein the ketone body or ketone precursor comprises beta-hydroxybutyrate (BHB), a precursor of beta-hydroxybutyrate, a derivative of beta-hydroxybutyrate, or a combination thereof.

### Claim 8 (depends on 1)

The nutritional health supplement of claim 1, further comprising an antioxidant that delays neuronal death under excitotoxic conditions.

### Claim 9 (depends on 8)

The nutritional health supplement of claim 8, wherein the antioxidant that delays neuronal death under excitotoxic conditions comprises riboflavin.

### Claim 10 (depends on 1)

The nutritional health supplement of claim 1, further comprising a branched chain amino acid (BCAA).

### Claim 11 (depends on 10)

The nutritional health supplement of claim 10, wherein the BCAA comprises leucine, isoleucine, valine, or a combination thereof.

### Claim 12 (depends on 1)

The nutritional health supplement of claim 1, further comprising a mitochondrial dysfunction mitigator with antioxidant and anti-inflammatory properties.

### Claim 13 (depends on 12)

The nutritional health supplement of claim 12, wherein the mitochondrial dysfunction mitigator with antioxidant and anti-inflammatory properties comprises curcumin and/or a curcumin derivative.

### Claim 14 (depends on 1)

The nutritional health supplement of claim 1, further comprising an antioxidant with free-radical species-deactivating properties.

### Claim 15 (depends on 14)

The nutritional health supplement of claim 14, wherein the antioxidant with free-radical species-deactivating properties comprises glutathione.

### Claim 16 (depends on 1)

The nutritional health supplement of claim 1, further comprising elemental magnesium, a magnesium salt, or a combination thereof.

### Claim 17 (depends on 1)

The nutritional health supplement of claim 1, wherein the nutritional health supplement is a powder for administration via a beverage.

### Claim 18

A nutritional health supplement, comprising:
a first neuroprotective agent, the first neuroprotective agent having antioxidant, anti-inflammatory, anti-apoptic, anti-autophagic, and anti-cerebral edema properties, and having calcium-induced apoptotic signaling-inhibiting properties;
a second neuroprotective agent, the second neuroprotective agent having glutamate-mediated excitotoxicity-mitigating and calcium influx-mitigating properties and having antioxidant and blood-brain barrier protecting properties;
a third neuroprotective agent that is a precursor for glutathione synthesis and has calcium influx-mitigating and anti-oxidative stress mediating properties, wherein the third neuroprotective agent augments the first neuroprotective agent's calcium-induced apoptotic signaling-inhibiting properties and anti-cerebral edema properties and the second neuroprotective agent's antioxidant properties; and
a ketone body or a ketone precursor that augments the first neuroprotective agent's anti-apoptic properties and the antioxidant properties of the first and second neuroprotective agents.

### Claim 19

A multi-stage nutritional health supplement for a brain, the multi-stage nutritional health supplement comprising:
a first stage adapted for administration during a period of activity having a likelihood of traumatic brain injury and for a first period of time, the first stage comprising;
a first neuroprotective agent, the first neuroprotective agent having antioxidant, anti-inflammatory, anti-apoptic, anti-autophagic, and anti-cerebral edema properties, and having calcium-induced apoptotic signaling-inhibiting properties;
a second neuroprotective agent, the second neuroprotective agent having glutamate-mediated excitotoxicity-mitigating and calcium influx-mitigating properties and having antioxidant and blood-brain barrier protecting properties;
a third neuroprotective agent that is a precursor for glutathione synthesis and has calcium influx-mitigating and anti-oxidative stress mediating properties, wherein the third neuroprotective agent augments the first neuroprotective agent's calcium-induced apoptotic signaling-inhibiting properties and anti-cerebral edema properties and the second neuroprotective agent's antioxidant properties; and
either:
a) a NAD+ precursor, wherein the NAD+ precursor augments the first neuroprotective agent's anti-apoptotic properties, the second neuroprotective agent's glutamate-mediated excitotoxicity-mitigating and blood-brain barrier protecting properties, and the third neuroprotective agent's calcium influx-mitigating and anti-oxidative stress mediating properties,
b) a ketone body and/or a ketone precursor that augments the first neuroprotective agent's anti-apoptic properties and the antioxidant properties of the first and second neuroprotective agents, or
c) a combination of a) and b),
wherein the second neuroprotective agent augments the third neuroprotective agent's calcium influx-reducing property, and
a second stage adapted for administration after a symptomatic traumatic brain injury and for a second period of time, the second stage comprising;
the first neuroprotective agent;
the second neuroprotective agent;
the third neuroprotective agent; and
either:
d) the NAD+ precursor,
e) the ketone body or the ketone precursor, or
f) a combination of d) and e).

### Claim 20 (depends on 19)

The multi-stage nutritional health supplement of claim 19, wherein the second neuroprotective agent is present in the second stage in in an amount that is greater than an amount of the second neuroprotective agent in the first stage, and wherein the NAD+ precursor is present in the second stage in an amount that is greater than an amount of the NAD+ precursor in the first stage.
